Kolli Sreelakshmi 4

What Happened

• Kolli Sreelakshmi, a member of the Board of Directors of Zimmer Biomet Holdings, Inc. (ZBH), was granted 175.404 phantom stock units on 2026-03-31. The units were recorded as an award (code A) at $0.00 acquisition price (derivative security).
• These phantom units are rights to receive company common stock later (not immediate stock ownership). The filing notes a 1-for-1 conversion/exercise ratio and that units will be settled in shares within 60 days after the reporting person stops serving as a director. The grant includes 15.067 units credited on January 30, 2026 under the plan’s dividend reinvestment provision.

Key Details

• Transaction date: 2026-03-31. Report filed with the SEC on 2026-04-02 (appears timely).
• Transaction type/code: Award/grant of derivative securities (A).
• Price: $0.00 reported for the acquisition of the phantom units (no cash paid).
• Conversion: 1-for-1 conversion into common shares (per footnote).
• Settlement: Units to be settled in shares within 60 days after cessation of director service.
• Footnotes of note: units accrued under the Zimmer Biomet Deferred Compensation Plan for Non-Employee Directors; includes 15.067 units from dividend reinvestment.
• Shares owned after transaction: Not specified in the provided filing excerpt.

Context

• Phantom stock units are a form of deferred compensation for non-employee directors: they track the value of common stock but do not confer current share ownership or voting rights until settled. They should be viewed as compensation rather than an immediate market purchase or sale.
• This award is routine director compensation and does not by itself indicate the director is buying or selling shares in the open market.